Abstract:Objective To explore the therapeutic effect and possible mechanism of free radical scavenger edaravone on oxygen-induced retinopathy in suckling rats. Methods According to the random number method, 60 suckling rats were divided into normal control group, hyperoxia induction group and drug treatment group, with 20 rats in each group. Hyperbaric oxygen treatment was applied to establish the retinopathy of prematurity (ROP) model. The retinal superoxide dismutase (SOD) activity and malondialdehyde (MDA) content were determined by xanthine oxidase method. Hematoxylin-eosin (HE) staining was used to observe the pathological changes of the retina. Adenosine diphosphate (ADP) staining was used to determine the non-perfusion area of the retina. Immunohistochemical staining was used to determine the expression of vascular endothelial growth factor (VEGF) and CD34 in the retina. Results The weights of the three groups of suckling rats were compared at each time point, and the repeated measures design was used to analyze the variance. The body weight of the suckling rats at different time points was different (F?=?19.055, P?=?0.000). There were also differences in the weight of the suckling rats among the three groups (F?=?31.229, P?=?0.000). Besides, the changing trend of the weights of suckling rats in each group was different (F?=?3.688, P?=?0.000). There were statistically significant differences in retinal SOD activity, MDA content, as well as optical density of VEGF and CD34 among the three groups of suckling rats (P?0.05). Compared with the normal control group, the hyperoxia induction group had decreased retinal SOD activity (P?0.05), increased MDA content (P?0.05), and increased integrated and average optical density of VEGF and CD34 (P?0.05). Compared with the hyperoxia induction group, the drug treatment group had increased retinal SOD activity (P?0.05), decreased MDA content (P?0.05), reduced non-perfusion area of the retina (P?0.05), and lower integrated and average optical density of VEGF and CD34 (P?0.05). HE staining showed that there was no lesion in the retina of the normal control group. In hyperoxia induction group, there was neovascularization, vasodilatation and bleeding in the retina. However, the lesions in the retina were improved in the drug treatment group than those in the hyperoxia induction group and no bleeding was observed. Conclusions Edaravone has a protective effect on oxygen-induced retinopathy, and can inhibit retinal oxidative stress response and neovascularization.